Muscular dystrophy arises from defects in many different single genes. Mutations in the genes encoding dystrophin or the sarcoglycans elicit a similar phenotype of progressive muscle weakness accompanied by dilated cardiomyopathy. The relationship between dystrophin and sarcoglycan loss is further reinforced by the assembly of these proteins into the dystrophin glycoprotein complex (DGC). The DGC plays a key role in stabilizes the plasma membrane against the forces associated with repetitive contraction. As both cardiac and skeletal muscle face repeated contraction, both heart and muscle are damaged by loss of the DGC. Mutations in ?-sarcoglycan lead to a recessive form of muscular dystrophy, similar to what occurs in Duchenne Muscular Dystrophy (DMD). There is a single mutation responsible for ?-sarcoglycan, 521?T, that has been described in LGMD patients from around the world. Despite the presence of the identical gene mutation, there is considerable phenotypic variability with this mutation. Similarly, in DMD, brothers sharing the same mutation may have a discrepant disease process. We sought to identify genes that modify the outcome of muscular dystrophy using a mouse model of ?-sarcoglycan mutations, Sgcg null. We selected this model because of the strong evidence for genetic modifiers in the corresponding human disease and because we reasoned that such modifiers could point to pathways that may be useful for therapeutic intervention. Using the Sgcg null model, we recently identified LTBP4, a TGF? binding protein, as a modifier of muscle disease.

Public Health Relevance

We mapped modifiers of muscular dystrophy by identifying two distinct background strains, D2 and 129, that lead to severe and mild forms of muscle disease, respectively. We propose to use a similar strategy to understand modifiers of cardiac function in muscular dystrophy.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZNS1-SRB-S)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
United States
Zip Code
Posey Jr, Avery D; Swanson, Kaitlin E; Alvarez, Manuel G et al. (2014) EHD1 mediates vesicle trafficking required for normal muscle growth and transverse tubule development. Dev Biol 387:179-90
Villalta, S Armando; Rosenthal, Wendy; Martinez, Leonel et al. (2014) Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy. Sci Transl Med 6:258ra142
Moorwood, Catherine; Barton, Elisabeth R (2014) Caspase-12 ablation preserves muscle function in the mdx mouse. Hum Mol Genet 23:5325-41
Dorn 2nd, Gerald W; McNally, Elizabeth M (2014) Two strikes and you're out: gene-gene mutation interactions in HCM. Circ Res 115:208-10
Swaggart, Kayleigh A; McNally, Elizabeth M (2014) Modifiers of heart and muscle function: where genetics meets physiology. Exp Physiol 99:621-6
Ermolova, N V; Martinez, L; Vetrone, S A et al. (2014) Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function. Neuromuscul Disord 24:583-95
Smith, Lucas R; Barton, Elisabeth R (2014) Collagen content does not alter the passive mechanical properties of fibrotic skeletal muscle in mdx mice. Am J Physiol Cell Physiol 306:C889-98
Fahrenbach, John P; Andrade, Jorge; McNally, Elizabeth M (2014) The CO-Regulation Database (CORD): a tool to identify coordinately expressed genes. PLoS One 9:e90408
Puckelwartz, Megan J; Pesce, Lorenzo L; Nelakuditi, Viswateja et al. (2014) Supercomputing for the parallelization of whole genome analysis. Bioinformatics 30:1508-13
Forbes, Sean C; Willcocks, Rebecca J; Triplett, William T et al. (2014) Magnetic resonance imaging and spectroscopy assessment of lower extremity skeletal muscles in boys with Duchenne muscular dystrophy: a multicenter cross sectional study. PLoS One 9:e106435

Showing the most recent 10 out of 60 publications